SCARA5 and cancer: Accumulated studies have demonstrated the abnormal expression of SCARA5 in several cancers, including lung Adenocarcinoma (Yu et al. 2020b), breast cancer (Mamoor 2020), hepatocellular carcinoma (Liu et al. 2018a), and oral squamous cell carcinoma (Liu et al. 2018c).